Double Helix Bio-technology Development
1995
FOUNDED
M&A
STATUS
51-60
EMPLOYEES
M&A
LATEST DEAL TYPE
1
FINANCING ROUNDS
Description
Provider of market research and consulting services to the healthcare industry. The company offers market research, data analytic, market advisory, planning and consulting, strategy management and pharmaceutical market information services to the healthcare organizations.
Website
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Healthcare Services
Other Industries
Other Commercial Services
Consulting Services (B2B)
Acquirer
McCann Health
Primary Office
- 88 Baker Street
- London W1U 6TQ
- England, United Kingdom
Double Helix Bio-technology Development Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Double Helix Bio-technology Development‘s full profile, request access.
Request full access to PitchBookDouble Helix Bio-technology Development Executive Team (3)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Charlie Buckwell | Chief Executive Officer | ||
| Jim Goldenberg | President |
1 Former Executive
You’re viewing 2 of 3 executives. Get the full list »